Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,538 | -13,206 | -59,363 | -23,724 | -22,242 |
| Depreciation Amortization | 636 | 175 | 684 | 490 | 334 |
| Accounts receivable | -1,152 | -723 | -1,979 | -1,477 | -537 |
| Other Working Capital | -6,711 | -407 | 739 | -3,236 | 1,269 |
| Other Operating Activity | 476 | 3,294 | 9,341 | -13,454 | 1,437 |
| Operating Cash Flow | $-24,289 | $-10,867 | $-50,578 | $-41,401 | $-19,739 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -126 | -66 | -588 | -216 | -38 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -66 |
| Other Investing Activity | 0 | 0 | -1,000 | -1,000 | -66 |
| Investing Cash Flow | $-126 | $-66 | $-1,588 | $-1,216 | $-104 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 0 | N/A | 0 | N/A |
| Debt Repayment | -43 | -22 | -87 | -65 | -43 |
| Common Stock Issued | 6,755 | 3,148 | 179 | 94 | 66 |
| Other Financing Activity | -2,593 | 0 | 54,537 | 54,557 | 14,310 |
| Financing Cash Flow | $29,119 | $3,126 | $54,629 | $54,586 | $14,333 |
| Beginning Cash Position | 12,127 | 12,127 | 9,664 | 9,664 | 9,664 |
| End Cash Position | 16,831 | 4,320 | 12,127 | 21,633 | 4,154 |
| Net Cash Flow | $4,704 | $-7,807 | $2,463 | $11,969 | $-5,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,289 | -10,867 | -50,578 | -41,401 | -19,739 |
| Capital Expenditure | -126 | -66 | -588 | -216 | -38 |
| Free Cash Flow | -24,415 | -10,933 | -51,166 | -41,617 | -19,777 |